University College London
Bioprocessing of New Medicines (Business and Management)
Typical offer rate
68–78%
moderate entry
Typical entry
AAA
Grad employment
90%
15 months after
In professional roles
65%
Median grad salary
£34,000
15 months after
UCL's Bioprocessing of New Medicines (Business and Management) programme examines the technical and commercial dimensions of bringing new biopharmaceuticals from laboratory to market, combining bioprocessing science with business strategy and management. Offers go to a fair share of those who meet the grades; offers are made around AAA at A-level.
How hard is it to get in?
The typical applicant to Bioprocessing of New Medicines (Business and Management) at University College London has a 68–78% chance of an offer, moderate by UK standards. Most offers are made around AAA at A-level. That baseline is course-typical. Your own chance depends on your grades, subjects and the rest of your profile.
See your personalised chances
Unimetrica estimates your individual offer likelihood for this course from your predicted grades and profile. It shows how it fits into your best five UCAS choices.
Estimate my chancesEntry requirements
- Typical A-level grades: AAA
- UCAS tariff: 144–144 points
About University College London
University College London was the first university in England to admit students regardless of religion and among the first to admit women, on its Bloomsbury campus in central London.
Full details and how to apply are on the university's official course page: University College London · Bioprocessing of New Medicines (Business and Management)
Offer rate and graduate-outcome figures are course-typical baselines derived from UK admissions and HESA data; they are estimates, not guarantees. Your personalised offer likelihood is calculated in the Unimetrica app.